top of page
Can You Describe The Ruckus
Milton
Dec 23 min read
BMS's Never-Ending Layoff Saga: Because Nothing Says 'Happy Holidays' Like Pink Slips
Just when you thought Bristol Myers Squibb had finished its epic game of corporate musical chairs, they've decided to pull out even more...
0 views0 comments
Milton
Dec 23 min read
The Spectacular Unwinding of Lexicon: A Masterclass in How Not to Run a Biopharma
In what can only be described as a stunning display of pharmaceutical mismanagement, Lexicon Pharmaceuticals has managed to achieve what...
0 views0 comments
Milton
Oct 232 min read
The McKinsey-fication of Takeda: Another Corporate 'Efficiency Program' Claims Jobs
Takeda offered "limited details" on what its "efficiency program" would entail. The company said it would focus on "organizational...
0 views0 comments
Milton
Oct 232 min read
Accountability? At Pfizer? It's About Time
Look, I'm not trying to pick on Pfizer here, but they keep giving me material that's impossible to ignore. And finally, someone with...
0 views0 comments
Milton
Oct 232 min read
The Plot Thickens: Pfizer's Leadership Drama Takes a Suspicious Turn
Bit delayed in posting this one, but here goes... In what feels like a corporate soap opera, Pfizer's latest episode with activist...
0 views0 comments
Milton
Oct 102 min read
Pfizer's $525 Million Lesson in How Not to Do an Acquisition
Is anyone else feeling a sense of déjà vu? Once again, we're witnessing a pharmaceutical giant fumble a multi-million dollar acquisition,...
0 views0 comments
Milton
Sep 272 min read
Bristol Myers Squibb's CAR-T Conundrum: When Your Race Car Hits a Speed Bump
Hey there, pharma fanatics! Buckle up, because we're about to take a wild ride through the twisty world of CAR-T therapy, where Bristol...
0 views0 comments
Milton
Sep 272 min read
Pfizer's $5.4 Billion Oopsie: The Curious Case of Oxbryta's Market Exit
Hey there, pharma watchers! Grab your popcorn, because we've got a doozy of a story today. Remember when Pfizer splurged $5.4 billion to...
1 view0 comments
bottom of page